Pharming Group (Netherlands) Today
| PHARM Stock | EUR 0.80 0.01 1.23% |
PerformanceVery Weak
| Odds Of DistressLow
|
Pharming Group is trading at 0.8 as of the 21st of March 2025, a 1.23 percent down since the beginning of the trading day. The stock's open price was 0.81. Pharming Group has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Pharming Group N.V., a specialty pharmaceutical company, develops and manufactures biopharmaceutical products in the United States, Europe, and internationally. Pharming Group N.V. is headquartered in Leiden, the Netherlands. PHARMING GROUP operates under Biotechnology classification in Netherlands and is traded on Amsterdam Stock Exchange. The company has 652.41 M outstanding shares. More on Pharming Group NV
Moving together with Pharming Stock
Moving against Pharming Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Pharming Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pharming Group's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pharming Group or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Pharming Group NV (PHARM) is traded on Euronext Amsterdam in Netherlands and employs 277 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 811.08 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharming Group's market, we take the total number of its shares issued and multiply it by Pharming Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pharming Group NV operates under Healthcare sector and is part of Biotechnology industry. The entity has 652.41 M outstanding shares.
Pharming Group NV has accumulated about 63.89 M in cash with 37.84 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1.
Check Pharming Group Probability Of Bankruptcy
Ownership AllocationPharming Group owns a total of 652.41 Million outstanding shares. Roughly 81.6 pct. of Pharming Group outstanding shares are held by general public with 1.97 % owned by insiders and only 16.43 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Pharming Ownership Details
Pharming Group NV Risk Profiles
Although Pharming Group's alpha and beta are two of the key measurements used to evaluate Pharming Group's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.91 | |||
| Standard Deviation | 3.15 | |||
| Variance | 9.93 | |||
| Risk Adjusted Performance | (0.02) |
Pharming Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pharming Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Pharming Group Corporate Management
Elected by the shareholders, the Pharming Group's board of directors comprises two types of representatives: Pharming Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pharming. The board's role is to monitor Pharming Group's management team and ensure that shareholders' interests are well served. Pharming Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pharming Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bruno Giannetti | Consultant | Profile | |
| Susanne Embleton | Investor Mang | Profile | |
| Jeroen Wakkerman | Chief Officer | Profile | |
| Ruud Outersterp | Chief Officer | Profile | |
| Stephen Toor | Chief Americas | Profile | |
| Anurag Relan | Chief Officer | Profile | |
| MBA MD | CEO Pres | Profile |
Additional Information and Resources on Investing in Pharming Stock
When determining whether Pharming Group NV is a strong investment it is important to analyze Pharming Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pharming Group's future performance. For an informed investment choice regarding Pharming Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.